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ABSTRACT 
Unilateral dialysis of the broad-spectrum muscarinic receptor antagonist atropine (50 mM) into the 
ventral respiratory column [(VRC) including the pre-Bötzinger complex region] of awake goats increased 
pulmonary ventilation (V�i) and breathing frequency (f), conceivably due to local compensatory increases 
in serotonin (5-HT) and substance P (SP) measured in effluent mock cerebral spinal fluid (mCSF). In 
contrast, unilateral dialysis of a triple cocktail of antagonists to muscarinic (atropine; 5 mM), neurokinin-
1, and 5-HT receptors does not alter V�i or f, but increases local SP. Herein, we tested hypotheses that 1) 
local compensatory 5-HT and SP responses to 50 mM atropine dialyzed into the VRC of goats will not 
differ between anesthetized and awake states; and 2) bilateral dialysis of the triple cocktail of 
antagonists into the VRC of awake goats will not alter V�i or f, but will increase local excitatory 
neuromodulators. Through microtubules implanted into the VRC of goats, probes were inserted to 
dialyze mCSF alone (time control), 50 mM atropine, or the triple cocktail of antagonists. We found 1) 
equivalent increases in local 5-HT and SP with 50 mM atropine dialysis during wakefulness compared 
with isoflurane anesthesia, but V�i and f only increased while awake; and 2) dialyses of the triple cocktail 
of antagonists increased V�i, f, 5-HT, and SP (<0.05) during both day and night studies. We conclude that 
the mechanisms governing local neuromodulator levels are state independent, and that bilateral 
excitatory receptor blockade elicits an increase in breathing, presumably due to a local, 
(over)compensatory neuromodulator response. 
NEW & NOTEWORTHY 
The two major findings are as follows: 1) during unilateral dialysis of 50 mM atropine into the ventral 
respiratory column to block excitatory muscarinic receptor activity, a compensatory increase in other 
neuromodulators was state independent, but the ventilatory response appears to be state dependent; 
and 2) the hypothesis that absence of decreased V�i and f during unilateral dialysis of excitatory receptor 
antagonists was due to compensation by the contralateral VRC was not supported by findings herein. 
Although it is well accepted that all neuronal networks are highly modulated by excitatory and inhibitory 
neurochemicals, the control of neuromodulators is not well understood. Mechanisms have been 
postulated to prevent excesses and deficits in excitatory or inhibitory neuromodulation.17 Such 
mechanisms are critical for stabilizing a network against the multiple neuromodulators acting within a 
given neuronal network. Dysfunction of these mechanisms may underlie or contribute to diseases such 
as Parkinson’s disease, epilepsy, schizophrenia, and depression; thus there is a need for studies on 
control of neuromodulators. 
Insights into control of neuromodulators have been obtained by studies on neuromodulation of 
respiratory control networks. For example, acetylcholine,3, 4, 6, 20 substance P (SP),13, 22, 23 and serotonin 
(5-HT)23, 25, 29 are generally excitatory to breathing and are important excitatory neuromodulators of the 
pre-Bötzinger complex (preBötC), which is critical for respiratory rhythm generation.1, 26, 27 In rhythmic 
brain stem slice preparations, Doi and Ramirez10, 11 found that administration of an SP receptor 
[neurokinin-1 (NK-1); RP67580] antagonist reduced fictive respiratory frequency, but the same 
antagonist did not alter spontaneous breathing when injected into the preBötC in young, urethane-
anesthetized mice. However, if the NK-1 receptor antagonist was injected concurrently with antagonists 
of α1-noradrenergic and 5-HT2A receptors, spontaneous respiratory frequency was reduced and 
irregularity increased. These findings support the concept of neuromodulatory interdependence, 
whereby changes in one neuromodulator are compensated by local changes in other neuromodulator(s) 
to maintain normal neuronal network function and/or breathing.10, 11 
Further support for a local neuromodulatory compensation within the neural respiratory network was 
provided by Muere et al.,20–23 who found that unilateral microdialysis of antagonists to muscarinic, NK-1, 
or 5-HT2A receptors, individually or in combination, into the ventral respiratory column (VRC; near the 
preBötC) of awake goats did not alter pulmonary ventilation (V�i) and breathing frequency (f). However, 
the investigators also found significant changes in the levels of excitatory and/or inhibitory 
neuromodulators in the effluent dialysate on the ipsilateral (but not contralateral) side of antagonist 
dialysis, which could have compensated for the presumed decrease in local cellular activity via the 
reduced activity of muscarinic, NK-1, and 5-HT2A receptors.20–23 These data suggest that there are 
mechanisms within the network that monitor the activation of receptors and quickly compensate with 
an increased release of neuromodulators when receptor activity has been decreased. Such a mechanism 
is very specific and is different from those proposed by Marder17 to prevent deficits and excess in 
neuromodulation. However, either through anatomic connections or other undetectable reflex 
mechanisms, the contralateral VRC could also be contributing to compensation and maintenance of V�i 
and f during excitatory receptor blockade. Accordingly, one major goal of the present study was to 
determine if bilateral dialysis into the VRC of antagonists to excitatory neuromodulator receptors also 
does not alter V�i and f. Consistent with the concept of neuromodulatory interdependence, we 
hypothesized that bilateral dialysis of antagonists to muscarinic, NK-1, and 5-HT2A receptors will not 
alter V�i and f, but would result in compensatory changes in neuromodulators. 
Simultaneous administration into the preBötC of multiple excitatory receptor antagonists decreased 
respiratory activity in in vitro and in vivo anesthetized rodent preparations,11 but simultaneous dialysis 
into this region of multiple antagonists did not decrease V�i and f in awake and sleeping goats.23 This 
difference could be due to a state dependence of compensatory increases in neuromodulators with 
receptor blockade, whereby anesthesia may alter the fundamental mechanisms governing local 
neurochemical release. Accordingly, a second goal of the present study was to test the hypothesis that, 
during unilateral dialysis of 50 mM atropine into the VRC, the expected increases in SP and 5-HT 




Studies were on nine nonpregnant female adult goats (48 ± 7.9 kg). The goats were housed and studied 
in an environmental chamber with ambient temperature and a controlled light-dark cycle (lights on 6:00 
AM to 6:00 PM). With the exception of a 24-h fasting period before surgery and during study protocols, 
food and water were otherwise freely available. The goats were acclimated to required study 
instrumentation [mask, valve, electroencephalogram (EEG)/electrooculogram (EOG) cables] and to 
standing and/or lying in the sternal position in a stanchion before the initiation of studies. All animal 
care and study protocols were approved by the Medical College of Wisconsin’s Institutional Animal Care 
and Use Committee before studies were completed. 
Experimental design. 
After arrival, goats were allowed to acclimate for at least 72 h before two surgical procedures, each 
separated by 2 wk. After 2 wk of recovery from the second surgery, the goats were studied in the 
awake, sleep, and anesthetized state for 4-6 wk thereafter. At the completion of the protocol, goats 
were euthanized and the brain tissue was extracted for histological confirmation of microtubule (MT) 
placement. 
Surgical procedures. 
Before beginning surgery, goats were anesthetized with ketamine [intravenous (IV)], intubated, and 
then mechanically ventilated with isoflurane in 100% oxygen for the duration of the surgery. During and 
for 24 h after surgery, rectal body temperature (TR), oxygen saturation, and heart rate (HR) were 
continuously monitored. Postoperative monitoring occurred at scheduled intervals for 2 wk following 
surgeries. For pain control, goats were given flunixin meglumine (2 mg/kg) before surgery and once daily 
for 2 days thereafter. To minimize the risk of infection following surgery, triple antibiotic ointment was 
applied to all surgical sites daily for 1 wk. Additionally, ceftriaxone (25 mg/kg iv) was administered twice 
daily for 3 days, starting the morning of surgery for craniotomy procedures. The antibiotics ceftiofur 
sodium (Naxcel, 4 mg/kg im) and gentamicin (6 mg/kg im) were administered chronically once daily for 
the remainder of the protocol. To minimize cerebral edema following the craniotomy procedure, 
dexamethasone (4 mg/ml) was administered three times a day for the first 3 days following surgery, 
then tapered off to twice daily for 1 wk after surgery. 
In the initial surgery, EEG and EOG electrodes were implanted in the midline cranium and superior 
orbital ridge, respectively. The electrodes were implanted using steel screws and secured with dental 
acrylic and were used to record brain activity to score sleep state during night studies. Additionally, 
during the same procedure, a carotid artery was relocated and secured just beneath the skin. This 
procedure facilitated subsequent chronic catheterization of the artery for recording blood pressure (BP), 
HR, and sampling arterial blood for gas analysis. 
After at least 2 wk of recovery, the second surgery was performed to chronically implant unilaterally (n = 
2) or bilaterally (n = 7) stainless steel MTs (70.0 mm length, 1.27 mm outer diameter, 0.84 mm inner 
diameter) into the VRC, including the preBötC region. After the occipital craniotomy, an incision was 
made in the dura mater to visualize the brain stem and cerebellum. Once obex was visualized, a 
stereotaxic device and predetermined coordinates (2.5–3.5 mm rostral to obex, 4.0–5.0 mm lateral to 
midline, and 4.0–6.0 mm from the dorsal surface of the medulla) were utilized to place the MT(s) into 
the preBötC region of the VRC. These coordinates were based on previous studies in goats.15, 33 
Occasionally, placement had to be slightly altered to avoid blood vessels. To secure the MT(s), screws 
were placed in the cranium, and the craniotomy was then filled with dental acrylic. The incision was 
closed with suture, and stainless steel stylets were inserted into the MT(s), such that they did not 
penetrate the tissue. Triple antibiotic ointment and bandages were applied to all surgical sites. Following 
surgery, the goats were monitored for at least 24 h by experienced laboratory staff. 
Physiological data collection. 
Following the second surgery, the goats were allowed a minimum of 2 wk to recover before the 
initiation of studies. During this time, the goats were accustomed to the study apparatus and protocol. 
To measure ventilatory data, a custom-made mask was specially fitted to each animal and secured to 
their muzzles during studies. A two-way valve was inserted into the end of the mask, and tubing was 
attached to inspiratory and expiratory sides of the valve. The inspiratory tubing was attached to a 
pneumotachograph connected to a Windaq data recording system and used to obtain breath-by-breath 
V�i (l/min), f (breaths/min), tidal volume (Vt, l/breath), inspiratory (Ti) and expiratory (Te) time (s), and 
inspiratory drive (Vt/Ti). During daytime studies, the expiratory tubing was attached to a Tissot 
spirometer. The expired air was collected at 5-min intervals and analyzed for O2 and CO2 concentration 
for calculation of O2 consumption. Additionally, at least every 30 min of each protocol, arterial blood 
was withdrawn from a catheterized carotid artery for analysis of pH, Pco2, and Po2. The arterial catheter 
line was attached to a transducer to obtain BP and HR using the Windaq data analysis system. To 
determine and score sleep state during night studies, signals from EEG and EOG electrodes were 
recorded and later scored always by the same investigator. Finally, TR was recorded throughout the 
studies herein. 
Glutamate receptor agonist injection studies. 
Increased f has been observed following injection of a glutamate receptor agonist into the region of the 
preBötC region of the VRC.20–23 Accordingly, as in prior studies, injections of N-methyl-d-aspartic acid 
(NMDA) were used as a physiological indicator of the proximity of MT(s) placement to the preBötC 
target area. During these studies in the awake state, either 500 nl of mCSF or 500 nl of NMDA (100 mM) 
were injected into the MTs, separated by at least 30 min. Ventilatory data were measured as described 
above. 
Microdialysis studies. 
Microdialysis day studies were completed between 9 AM and 2 PM, and night studies were between 8 
PM and 2 AM All studies were separated by a minimum of 36 h. Microdialysis probes (HSP Harvard 
Apparatus) were 72 mm in length, with the final 2 mm being a porous membrane (0.5-mm membrane 
diameter, 2-kDa cut off, 3-μl internal volume). Only the membrane portion of the probe penetrated the 
tissue when inserted into the MTs. Dialysis perfusate consisted of mCSF (124 mM NaCl, 2.0 mM KCl, 2.0 
mM MgCl2, 1.3 mM K2PO4, 2.0 mM CaCl2, 11 mM glucose, 26 mM NaHCO3−, and pH 7.32 in sterile 
water), with or without a dissolved drug. Before dialysis, the mCSF was equilibrated with 6.4% CO2, 12% 
O2, balance N2 and heated to 39°C utilizing a tonometer. For drug dialysis studies, either 50 mM atropine 
(Sigma, a0257) or a triple cocktail of 500 µM spantide (US Biological, S5370), 5 mM atropine, and 0.5 
mM MDL 11939 (Tocris, 0780) were dissolved in the mCSF. To completely dissolve the triple cocktail, a 
final concentration of 1.25% DMSO was required. To minimize behavioral responses of the goats during 
awake and sleep studies, the syringe pump (Harvard Apparatus) utilized for delivery of the solutions 
(flow rate: 25 μl/min) was located outside the study chamber. A 150- to 180-cm length of polypropylene 
tubing was used to connect the syringe with the dialysis probe; thus there was a delay of ~20 min 
between switching the pump on and dialysate reaching the probe. Following probe insertion, there was 
a 30-min acclimation period, followed by a 30-min control period and then 3 continuous hours of 
dialysis. During the first and third hours, only mCSF was dialyzed. During the second hour, the dialyzed 
solution was either 1) mCSF (day awake), 2) 50 mM atropine in mCSF (day awake and day anesthetized), 
or 3) triple cocktail in mCSF [day awake and night awake or in non-rapid-eye-movement sleep (NREM) 
sleep]. Effluent dialysate was collected in separate cryovials for each hour, aliquoted, and frozen for 
subsequent neurochemical analysis. 
For dialysis studies conducted under anesthesia, goats were anesthetized with ketaject (IV) and 
intubated. Anesthesia was maintained using a mechanical ventilator providing isoflurane in oxygen. In 
four of seven goats, the level of anesthesia was adjusted to prevent spontaneous breathing, and 
mechanical ventilation was adjusted accordingly to maintain arterial blood gases at control levels. In the 
other three goats, the anesthesia was adjusted to prevent movement, but breathing and arterial blood 
gases were not controlled. A custom-made apparatus was attached to the endotracheal tube to allow 
recording of breathing via a Windaq data recording system. Arterial blood was sampled at regular 
intervals. The dialysis protocol consisted of 1 h of mCSF dialysis, followed by 1 h of dialysis of 50 mM 
atropine, and then a third hour of mCSF alone. HR and BP were continuously monitored, and TR was 
recorded every 30 min. At the conclusion of the third hour of dialysis, the goats were allowed to recover 
from anesthesia and were supervised until fully alert and were then extubated. 
Neurochemical analysis. 
Effluent dialysate samples were submitted to an internal institution core laboratory facility for analysis 
of neuromodulator content, as cited by previous studies.20–23 To measure levels of glycine (Gly) and γ-
aminobutyric acid (GABA) reverse-phase liquid chromatography was used with the following 
parameters: Waters Resolve C18 column (150 × 3.9) with a fluorescent detector that was excited at 229 
nm and emits at 470 nm. The detector used a β-alanine standard and o-phthaldialdehyde derivatization. 
An identical column was used for the electrochemical detection of 5-HT; however, the potential was set 
at 0.6 V vs. an Ag/AgCl reference electrode using an N-methyl serotonin internal standard. To measure 
SP levels, a commercially available immunoassay was used (Assay Designs 900–018, range 9.76–10,000 
pg/ml) with a microplate reader at 405 nm. 
Data and statistical analysis. 
At the conclusion of each study, inspiratory flow and BP were calibrated. Subsequent breath-by-breath 
analysis was performed for V�i, f, Vt, Ti, Te, and Vt/Ti. Oxygen consumption was calculated at 5-min 
intervals from measured expired volume and expired O2 and CO2 concentrations. EEG and EOG signals 
recorded during night studies were used to determine sleep state for each breath. A single experienced 
investigator visually scored each breath as occurring during the awake, rapid eye movement (REM) sleep 
or NREM sleep state of consciousness. There was insufficient REM sleep for inclusion in statistical 
analyses. In all statistical analyses (detailed below), a P value < 0.05 was considered significant 
(Sigmaplot version 12.5 or greater). 
For day studies, the breath-by-breath data were compiled into 5- and 15-min bins, which were used for 
statistical analyses. The coefficient of variation (CV) in breath-by-breath V�i, f, and Vt was computed for 
5- and 15-min bins. To limit statistical analyses to stable conditions, we included only data in the last 15 
min of hour 1 (control dialysis), the final 45 min of hour 2 (drug dialysis), and all but the first 5 min of 
hour 3 (washout). For all ventilatory variables, two-way repeated-measures ANOVAs were used to 
compare triple cocktail and atropine dialyses to mCSF dialysis (one-factor repetition, with drug and time 
as factors). The Holm-Sidak post hoc test was used when appropriate. These statistics were completed 
both for the absolute ventilatory values and also after normalizing the second and third hour data to the 
last 15 min of hour 1 (%hour 1). The level of statistical significance was the same for absolute and 
normalized data and for 5- and 15-min bins; thus only the normalized 5-min bins are included in the 
results section for the day studies. 
For night studies, only 15-min bins were used for statistical analyses because the intermittent sleep 
pattern resulted in low numbers for 5-min bins. The CV in breath-by-breath V�i, f, and Vt was computed 
for 15-min bins. A two-way repeated-measures ANOVA with state and time (bin) as factors was used to 
determine whether there were significant differences between awake and NREM sleep states in the 
ventilatory responses to the triple cocktail dialysis. Additionally, a two-way repeated-measures ANOVA 
was used to compare the effect of bilateral triple cocktail dialysis during the day to the awake state at 
night (15-min bins). Finally, a one-way repeated-measures ANOVA was used to determine if there were 
significant ventilatory effects during the night awake or NREM sleep state during triple cocktail dialysis. 
Two determine whether changes in 5-HT, SP, Gly, GABA, and glutamate during dialyses of receptor 
antagonists differed between anesthetized and awake states or between day and night studies, a two-
way ANOVA was used. All significant P values from ANOVA analyses were followed by Holm-Sodak post 
hoc analysis. 
Histological confirmation of MT placement. 
After the completion of the study protocol, the goats were euthanized for tissue perfusion, fixation, and 
collection. Goats were first anesthetized with ketamine-xylazine (IV), one carotid artery was cannulated 
and the other ligated, and jugular veins were isolated. The goats were then euthanized (β-euthanasia, 
IV), the jugular veins opened, and the carotid artery was perfused with phosphate-buffered saline (PBS; 
volume 4–6 liters), followed by an equal volume of 4% paraformaldehyde in PBS. The brain stems were 
extracted, dehydrated (20% and 30% sucrose in PBS for 3–7 days each), and frozen (−80°C). The brain 
stems were serially sectioned at 25 µM in the transverse plane utilizing a microtome. One series of the 
sectioned brain stem tissue was then Nissl (cresyl violet) stained. Sections were imaged (4,000 dpi; 
Nikon Super Coolscan 9000) to determine the extent and location that the MTs penetrated the tissue. 
Metamorph image analysis software was then used to calibrate the images and measure the location of 
the MT(s) in millimeters. 
RESULTS 
Placement of MTs. 
The VRC in goats extends several millimeters along the ventrolateral aspect of the medulla (Fig. 1A). 
Within the VRC, the preBötC in goats is ~2.5–3.5 mm rostral to obex, 4−5 mm lateral to the midline, and 
4–6 mm from the dorsal surface of the medulla.16, 33 Based on postmortem histological analyses, 8 of 16 
MTs (in 9 goats) were placed such that the ventral-most aspect of the MT placement (indicated by 
numbers in Fig. 1A), or a conservative estimated region of diffusion of the dialyzed substances (gray 
boxes; Fig. 1A) reached the VRC. As in past studies, we also used the f response to the glutamate 
receptor agonist NMDA as a functional marker of proximity to the preBötC. We found that, in 11 of 14 
MT placements, injection of NMDA increased f to at least 115% of control, providing functional evidence 
of relative proximity to the preBötC (Fig. 1B). However, goats 2 and 3 had minimal or no response to 
NMDA, and the MTs were located in the most rostral region of the VRC. Because of some variation in 
the responses to NMDA and the corresponding histologically identified MT placement, and because it is 
very likely that the diffusion of administered substances with microdialysis were not restricted to the 
targeted regions (preBötC), we present and interpret our findings as effects within the VRC. However, 
the physiological responses to dialyses of 50 mM atropine and the triple antagonist cocktail were not 
different across all goats; thus all goats were included in group data. 
 Fig. 1. A: sections of the goat brain stem at three caudal to rostral distances from obex, depicting the microtubule 
placement in nine goats. Each goat is numbered (1–9), and the nos. for the left and right microtubule are located in 
the images, where the distal end of the microtubule was identified by postmortem histological analysis. The 0.5-
mm-wide porous membrane of the dialysis probe extended 2 mm beyond the distal end of the microtubule; thus 
we inserted a 2-mm long and 1-mm wide gray rectangle for each number to represent a conservative estimate of 
the region of diffusion of the dialyzed substances. The circle in each section is the approximate VRC in goats rostral 
to obex. B: quantitation of the breathing frequency response to NMDA injections displayed as percent increase 
from control levels before injection. Note goats 2 and 3 had unilaterally placed microtubules rostral to the 
preBötC, and these goats had the lowest response to NMDA injections. Note also that the left-side microtubule 
placement in goat 6 was the only case in which the rectangle did not extend to the estimated location of the VRC, 
which suggests widespread diffusion of NMDA in particular, but also dialyzed substances. CN, cuneate nucleus; 
FTL, lateral tegmental field; HP, nucleus praepositus hypoglossi; INT, nucleus intercalatus; IO, inferior olivary 
complex; IV, trochlear nucleus; NA, nucleus ambiguus; NTS, nucleus tractus solitarii; nX, vagus nerve; nXII, 
hypoglossal nerve; P, pyramidal tract; R, raphe nucleus; RB, restiform body; RG, nucleus gigantocellularis 
reticularis; 5SP, spinal trigeminal nucleus; 5ST, spinal trigeminal tract; TS, tractus solitaries; V, vestibular nucleus; X, 
dorsal motor nucleus of the vagus; XII, hypoglossal nucleus. 
 
Bilateral microdialysis of antagonists to multiple excitatory receptors. 
Our laboratory has shown previously that unilateral dialysis of the triple cocktail of antagonists to 
muscarinic, NK-1, and 5-HT2A receptors (5 mM atropine, 500 µM spantide, and 0.5 mM MDL in 1.25% 
DMSO; referred to as “triple cocktail” hereafter) during the day has no effect on V�i and f, but 
significantly alters local neurochemicals.23 Here, bilateral dialysis of the triple cocktail increased V�i (Fig. 
2A, P < 0.001) and f (Fig. 2B, P < 0.001), but did not alter Vt (Fig. 2C, P = 0.567) compared with dialysis of 
mCSF alone (n = 7), which was the case for all raw data and the hour 1-normalized data. The increased f 
with bilateral triple cocktail was due to decreased Ti (P = 0.001, Fig. 3A) and Te (P < 0.001, Fig. 3B), and 
there also was an increased drive to breath (as measured by Vt/Ti; P < 0.001, Fig. 3C). Bilateral triple 
cocktail dialysis did not significantly (P ≥ 0.422) alter variability of V�i, f, or Vt during the day, which was 
measured by CV in either 5-min or 30-min intervals (data not shown). Oxygen consumption (P = 0.022) 
and body temperature (P = 0.02, Fig. 4) were significantly increased during dialysis of the triple cocktail 
of receptor antagonists. BP, HR, and blood arterial Pco2 (PaCO2), and arterial Po2 were not significantly 
(P ≥ 0.095) affected by bilateral daytime triple cocktail dialysis (data not shown). 
 Fig. 2. During 180 min of bilateral dialysis during the day, the triple cocktail of antagonists to muscarinic, NK-1, and 
5-HT2A receptors (5.0 mM atropine, 500 µM spantide, 0.5 mM MDL) (●; n = 7) dialyzed between 60 and 120 min 
(indicated by horizontal solid line) significantly (P < 0.001) increased ventilation (V�i; A) and breathing frequency (f; 
B), but did not alter (P = 0.567) tidal volume (Vt; C) compared with bilateral dialysis of mCSF alone (○, n = 7). Values 
are means ± SE. The F and P values shown are the interaction terms obtained from two-way repeated-measures 
ANOVA using time and dose as factors. *Values during and after triple cocktail dialysis that differed from hour 1 
mCSF dialyses, as indicated by Holm-Sidak post hoc analysis. 
 
Fig. 3. During 180 min of bilateral dialysis during the day, the triple cocktail of antagonists to muscarinic, NK-1, and 
5-HT2A receptors (5.0 mM atropine, 500 µM spantide, 0.5 mM MDL) (●; n = 7) dialyzed between 60 and 120 min 
(indicated by horizontal solid line) significantly (P < 0.001) decreased inspiratory time (Ti; A) and expiratory time 
(Te; B) and increased respiratory drive (Vt/ Ti; C) during hours 2 and 3 compared with bilateral dialysis of mCSF 
alone (○, n = 7). Values are means ± SE. A two-way repeated-measures ANOVA using time and dose as factors was 
used to obtain the F and P values. *Values during and after triple cocktail dialysis that differed from hour 1 mCSF 
dialyses, as indicated by Holm-Sidak post hoc analysis. 
 
 Fig. 4. Daytime bilateral dialysis of a triple cocktail of antagonists to muscarinic, NK1, and 5-HT2A receptors (5.0 mM 
atropine, 500 µM spantide, 0.5 mM MDL) (●; n = 7) dialyzed between 60 and 120 min (indicated by horizontal solid 
line) significantly increased oxygen consumption (V�o2, P = 0.022; A) and body temperature (P = 0.02; B) compared 
with bilateral dialysis of mCSF alone (○, n = 7). Values are means ± SE. A two-way repeated-measures ANOVA (time 
and dose as factors) was used to determine if significant interactions occurred between treatments. *Values 
during and after triple cocktail dialysis that differed from hour 1 mCSF dialyses, as indicated by Holm-Sidak post 
hoc analysis. 
 
Consistent with previous findings of changes in local neurochemicals,23 daytime bilateral triple cocktail 
led to local increases in SP and 5-HT (P ≤ 0.033) measured in the effluent mCSF, but Gly, GABA, and 
glutamate were not affected (P ≥ 0.379, Fig. 5). With one exception, there was no difference (P ≥ 0.109) 
in the levels of all measured neurochemicals in the effluent collected from the left or right MT, but there 
were small but significant differences in Gly levels (P = 0.005) between sides (data not shown). 
 
Fig. 5. There were no significant differences between day and night studies in the measured neurochemical 
responses to the triple cocktail dialysis, as indicated by a two-way repeated-measures ANOVA using time and dose 
as factors (F and P values presented at the top left of each panel). Daytime (solid bars) and nighttime (shaded bars) 
bilateral dialysis of a triple cocktail of antagonists to muscarinic, NK-1, and 5-HT2A receptors (5.0 mM atropine, 500 
µM spantide, 0.5 mM MDL) during hour 2 of dialysis significantly (P ≤ 0.033) increased levels of substance P (A) and 
5-HT (B) in effluent mCSF during hour 2 and hour 3 of dialysis compared with dialysis of mCSF alone (open bars) (n 
= 7). C: glycine was significantly (P = 0.011) lower throughout the 3 h of mCSF dialysis compared with the 3 h when 
the triple cocktail was dialyzed in hour 2. GABA (D) and glutamine (E) were not significantly (P ≥ 0.379) altered by 
triple cocktail dialysis during the day or at night. Values are means ± SE. *Values during and after triple cocktail 
dialysis that differed from hour 1 mCSF dialyses, as indicated by Holm-Sidak post hoc analysis. Hr1–Hr3, hours 1–3. 
During bilateral triple cocktail dialysis at night, there was no significant difference in V�i (P = 0.129), f (P = 0.218), 
and Vt (P = 0.761) between awake and NREM sleep states, as indicated by the interaction term of two-way ANOVA 
(Fig. 6). Analysis of these data using one-way repeated-measures ANOVA (with time used as the factor) indicated 
there was an increase in f during both the awake (P = 0.002) and NREM states (P < 0.001), and an increase in V�i (P = 
0.007) during NREM sleep but not during the awake state. Vt was not significantly altered in either state at night. 
 
Fig. 6. A two-way repeated-measures ANOVA analysis of the effects of bilateral triple cocktail dialysis indicates that 
the ventilation (V�i; A), breathing frequency (f; B), and tidal volume (Vt; C) responses did not differ between awake 
(●) and NREM sleep (○) (F and P values, top left of each panel). B: bilateral dialysis of a triple cocktail of antagonists 
to muscarinic, NK1, and 5-HT2A receptors (5.0 mM atropine, 500 µM spantide, 0.5 mM MDL) (n = 5) (indicated by 
solid horizontal line) significantly (P ≤ 0.002) increased f at night during awake and NREM sleep states (one-way 
ANOVA). A: V�i was significantly increased during NREM sleep (P = 0.007), but not in the night awake state. C: Vt 
was not significantly affected in either state. Values are means ± SE. 
 
During the night studies, the CV for f (P = 0.038) and Vt (P = 0.04) within 15-min periods were greater for 
the awake state than for NREM sleep, as indicated by the interaction term of two-way ANOVA (Fig. 7). A 
one-way ANOVA indicated that, in the awake state at night, the triple cocktail significantly increased the 
CV for V�i (P = 0.042), f (P = 0.032), and Vt (P = 0.049), whereas, for NREM sleep, the triple cocktail only 
significantly increased the CVs for V�i (P = 0.039). The CVs for V�i, f, and Vt for night awake and for night 
NREM sleep were significantly (P < 0.05) greater than for day awake (comparisons not shown). 
 Fig. 7. During the night studies, the coefficient of variation (CV) for f (P = 0.038; B) and Vt (P = 0.04; C) within 15-
min periods was greater for the awake state (●) than for NREM slee (○), indicated by the interaction term of two-
way ANOVA (F and P at top left). A: the CV of V�i did not differ between awake and NREM sleep. A one-way ANOVA 
indicated that, in the awake state at night, the triple cocktail significantly increased the CV for V�i, f, and Vt (P < 
0.05), whereas for NREM sleep, the triple cocktail only significantly increased the CV for V�i (P = 0.039) (P, right 
side). The horizontal solid line in A denotes that the triple cocktail was dialyzed between 60 and 120 min. Values 
are means ± SE. 
 
For all neurochemicals, there was no significant difference between day and night studies in the 
responses to the triple cocktail, as indicated by F and P values (see top left of figure panels) from two-
way ANOVA. Similar to daytime studies, bilateral dialysis of the triple cocktail of antagonists at night 
resulted in a significant (P ≤ 0.021) increase in SP and 5-HT (Fig. 5). During hour 1 of dialysis when mCSF 
was dialyzed, there were no significant differences between day and night studies. 
Effects of unilateral dialysis of 50 mM atropine in awake and anesthetized goats. 
As in prior studies, unilateral dialysis of 50 mM atropine into the VRC of awake goats significantly (P < 
0.001) increased V�i, and f, but did not affect Vt (P = 0.578) compared with dialysis of mCSF alone (n = 8) 
(Fig. 8). In awake goats, dialysis of 50 mM atropine significantly (P < 0.001) increased SP and 5-HT, but 
glutamine, Gly, and GABA were unchanged (P ≥ 0.052) compared with dialysis of mCSF alone (Fig. 9). 
Unilateral dialysis of 50 mM atropine in anesthetized animals (n = 7) also significantly (P < 0.001) 
increased 5-HT and SP in effluent mCSF during hours 2 and 3 of studies compared with dialysis of mCSF 
dialysis during the first hour. In contrast, GABA was decreased significantly (P = 0.011) during hour 2, 
and glutamine and Gly were unaffected (P ≥ 0.052, Fig. 9). During 50 mM atropine dialyses, there were 
no significant (P ≥ 0.123) differences in effluent mCSF 5-HT, SP, Gly, or GABA levels between awake or 
anesthetized state, but glutamine levels was significantly (P = 0.034) greater during anesthesia (Fig. 9). 
 Fig. 8. Unilateral dialysis of 50 mM atropine during the day (n = 6; ●) (indicated by horizontal solid line) significantly 
(P < 0.001) increased ventilation (V�i; A) and breathing frequency (f; B), but did not significantly (P = 0.578) alter 
tidal volume (Vt; C) compared with mCSF time control studies (○). The F and P values are the interaction terms 
from two-way repeated-measures ANOVA using dose and time as factors. Values are means ± SE. *Values during 
and after atropine dialysis that differed from hour 1 mCSF dialyses, as indicated by Holm-Sidak post hoc analysis. 
 
Fig. 9. There were no statistically significant differences between the awake (open bars) and anesthetized (solid 
bars) state in substance P (A), 5-HT (B), glycine (C), or GABA (D) levels, as indicated by the F and P values from the 
interaction term (top left in each panel) of the two-way repeated-measures ANOVA. E: glutamine was significantly 
(P = 0.034) greater during anesthesia studies. Values are means ± SE. *For awake and anesthesia, unilateral dialysis 
of 50 mM atropine significantly (P < 0.001) increased substance P (A) and 5-HT (B) in effluent dialysate during both 
hours 2 and 3 (obtained from Holm-Sidak post hoc analysis). 
 
In four of seven goats studied under anesthesia, the ventilator was set to maintain a constant PaCO2 
within the range of control levels (Fig. 10). However, in three of the goats, we maintained a level of 
anesthesia in which they were immobilized but still able to breathe spontaneously. In two of these, we 
measured PaCO2, which increased during dialysis (Fig. 10). Near the end of the atropine dialysis, both 
goats stopped breathing spontaneously. Therefore, mechanical ventilation was initiated; however, 
PaCO2 remained elevated. 
 
Fig. 10. PaCO2 did not change during unilateral dialysis of 50 mM atropine in anesthetized goats that were 
mechanically ventilated (●). However, PaCO2 increased in goats under anesthesia that were not mechanically 
ventilated (▲ and ■). Values are means ± SE. 
DISCUSSION 
One aim of the present study was to test the hypothesis that combined bilateral dialysis of antagonists 
to muscarinic, NK-1, and 5-HT2A receptors into the VRC would not decrease V�i and f, but would result in 
compensatory changes in neuromodulators in the effluent mCSF. This hypothesis was validated as 
bilateral dialysis of these receptor antagonists paradoxically increased V�i and f with concomitant 
increases in local excitatory neuromodulators in the effluent mCSF. A second aim of the present study 
was to test the hypothesis that, during unilateral dialysis of 50 mM atropine, increases in SP and 5-HT in 
the effluent mCSF would not differ between anesthetized and awake states. This hypothesis was also 
validated as the increases in SP and 5-HT in the effluent mCSF did not differ between the awake and 
anesthetized states. 
Neuromodulator compensation in awake and sleeping states. 
Previous studies demonstrated that dialysis of atropine at one VRC site and simultaneously dialyzing 
mCSF at the contralateral VRC site, changes in neuromodulators measured in the effluent dialysate, only 
occurred at the site of atropine dialysis.20 These data suggested that the compensatory changes in 
neurochemicals in response to antagonist dialyses in the VRC were mediated by a local mechanism. 
However, it was unclear whether this local compensatory response was truly sufficient to overcome the 
presumptive local, unilateral decrease in cellular activity in the VRC in response to the antagonist. For 
example, the compensatory response to unilateral blockade of NK-1 receptors was a local increase in SP, 
which should have been an ineffective means for compensation if indeed NK-1 receptors are the 
primary/exclusive mediator of SP stimulation in this region.22, 23 Other potential contributing 
mechanisms to maintain V�i and f could be through anatomical connections with the contralateral 
preBötC/VRC, or through reflex compensation independent of neuromodulator changes on the 
contralateral side, which is a possibility supported by previous findings. Wenninger et al. found that 
abrupt bilateral destruction of the preBötC in awake goats caused terminal apnea,33 whereas abrupt 
unilateral destruction of this region induced several hours of hypoventilation without apnea.32 Also St-
Jacque and St-John28 found in decerebrate, vagotomized rats that attenuation of preBötC activity with 
unilateral injections of muscimol (inhibitory GABA agonists) resulted in several minutes of intermittent 
apneas but no terminal apnea. These examples demonstrate that respiratory rhythm continues with 
unilateral silencing of the preBötC, presumably due to compensation by the contralateral preBötC 
and/or redundancy within the control network. Accordingly, if indeed contralateral changes prevented 
V�i and f from decreasing during unilateral dialysis of receptor antagonists in our previous studies, then 
herein there should have been a decrease in V�i and f during bilateral dialysis of the antagonists. 
However, if local neuromodulator compensation is a robust mechanism as we postulated, a decrease in 
V�i and f during bilateral dialysis of multiple excitatory receptor antagonists should be prevented. 
The above hypothesis was validated, as bilateral dialysis of multiple excitatory receptor antagonists did 
not decrease V�i and f, but rather led to a paradoxical increase in breathing. The cause(s) of the increases 
in V�i and f during bilateral triple cocktail dialysis of excitatory receptor antagonists into the VRC is not 
known. There may be one or more explanations, including, but not limited to, changes in metabolic rate 
and body temperature, alterations of neuromodulators not yet measured in the local milieu, and/or 
compensation at the level of second-messenger pathways downstream of G protein-coupled receptors. 
The contribution of the increases in metabolic rate and body temperature is unclear, as the hyperpnea 
during dialysis of 50 mM atropine (Fig. 8) was not associated with increases in metabolic rate and body 
temperature, suggesting that these changes in triple cocktail dialysis might not be significant factors. 
Other potential contributors are the compensatory increases in SP and 5-HT, which could act through 
excitatory receptors other than those blocked herein (NK-1 and 5-HT2A receptors), or alternatively there 
may have been an increase in other neuromodulators, which we have yet to measure in the local 
neurochemical milieu. An example may be neuropeptide gamma (derived from the same promolecule as 
SP), which activates NK-2 receptors and may have also been increased with the antagonist dialysis. In 
addition, the receptors targeted by our antagonist cocktail all couple to G proteins of the Gq/11 subtype, 
which are linked to other receptors known to modulate neuronal activity in the VRC, such as α1-
adrenergic34 and P2Y purinergic12, 31 receptors. Thus another possibility that could account for the 
increase in V�i and f with the triple antagonist cocktail is that compensation could occur in second-
messenger systems downstream of common or additional G protein-coupled receptors, but we have no 
evidence to support this possibility. All three of the receptors we currently blocked converge on the 
same second-messenger system, the phospholipase C pathway; thus activity within this pathway may 
increase even though overall receptor activity decreased. Regardless of the cause, it is clear that 
bilateral blockade of three excitatory receptors resulted in what we consider an overcompensation, 
which also occurs with a high concentration of a single receptor antagonist (i.e., 50 mM atropine; Fig. 9). 
Marder and colleagues17, 18 have previously identified several potential mechanisms that could protect 
neural networks against overmodulation, which include the following: 1) a convergence of many 
modulators onto the same voltage-dependent current or on the same G protein-coupled receptor 
and/or G protein; 2) modulators coordinately acting on opposing cellular processes, 3) saturation of 
postsynaptic actions, and 4) compensation downstream of receptors by second-messenger signal 
transduction pathways. Despite such potentially protective mechanisms, our findings indicate that 
overmodulation can occur under physiological conditions, suggesting that there are limits in the 
mechanisms of compensatory neuromodulation and/or regulation of neuromodulators. 
Increases in metabolic rate and body temperature suggest there was a general excitatory physiological 
response to the dialysis of the triple cocktail of receptor antagonists herein. These findings are 
consistent with findings during triple cocktail dialysis during night studies when there was unstable 
breathing (Fig. 7), large variation in breathing between goats, absence of a difference in breathing 
between awake and NREM states (Fig. 6), and a relative low amount of NREM sleep in some of the 
goats. Indeed, two of seven goats (not included in the group data) remained awake throughout the 3-h 
dialysis protocol, and they had a large drug-induced increase in breathing. These findings are similar to 
effects observed in newborn piglets when Brown et al.7 dialyzed 8-OH-DPAT into the medullary raphe, 
which resulted in fragmented sleep with increases in the number and a decrease in the duration of 
bouts of NREM sleep and a marked decrease in amount of REM sleep. It seems conceivable that an 
overcompensation of neuromodulators may have prevented the normal change in neuromodulators 
that occurs with changes in state, such as sleep.4, 14 Indeed, unstable breathing occurs in transitions from 
wakefulness to NREM sleep9 during which there are major changes in excitatory neuromodulators. 
Dialysis of the triple cocktail of receptor antagonists may have created a type of “sleep disordered 
breathing,” or at least a lack of state transition and the subsequent associated changes in breathing. It 
seems clear that findings herein show that perturbations of neuromodulators at night during the normal 
sleep period have a major disruptive effect on sleep and on breathing during sleep. 
Effects of anesthesia on compensatory neuromodulation. 
It is well known that perturbations of the respiratory control network in anesthetized and/or reduced 
preparations have greater effects on breathing than perturbations in the awake state.10, 11 Doi and 
Rameriz11 found that simultaneously blocking two excitatory receptors in anesthetized rodents 
decreased respiratory activity. In contrast, we found that simultaneously blocking three excitatory 
receptors did not decrease V�i and f.23 One possible explanation for this difference among studies is that 
neuromodulatory compensation does not occur in the anesthetized state. This possibility led us to 
compare the neuromodulatory response to dialysis of 50 mM atropine in the anesthetized and awake 
states in the same goats. The major compensation in neurochemicals (5-HT and SP) in response to 50 
mM atropine did not differ between awake and anesthetized states, suggesting that the mechanism of 
local neurochemical compensation is the same in anesthetized and awake goats. Previously, our 
laboratory20 showed that the neurochemical compensation to 50 mM atropine during the day does not 
differ from compensation at night, even though there is a mixture of awake and NREM sleep states at 
night. Thus it appears that the fundamental mechanism(s) that facilitates neuromodulatory 
compensation occurs even when there are major, presumptive changes in the modulatory state 
between wakefulness and NREM sleep, and between wakefulness and anesthesia. Brain disorders, such 
as schizophrenia,5, 8 depression, and epilepsy,2, 24 and other disorders like Rett and Prader-Willi 
syndromes30 that are marked or defined by altered neuromodulators are likely associated with some 
degree of dysfunction in modulatory control systems. Thus a question that needs to be addressed is: 
does neuromodulator compensation occur normally in these disease states, or are these mechanisms 
aberrantly contributing to the dysfunction? Would neurochemical compensation occur normally after 
other experimental forms of respiratory-related dysfunction, such as carotid body denervation, which 
results in a major downregulation of excitatory neuromodulators, such as 5-HT?19 These questions 
emphasize the need for future studies on mechanisms/determinants of the modulatory state of the 
brain, which our in vivo goat model is well suited to address. 
In contrast to the local neuromodulatory response, the V�i and f response to 50 mM atropine appears to 
be state dependent.20 Under anesthesia, the goats were unable to maintain spontaneous breathing, 
even when hypoventilation caused a severe hypercapnia (Fig. 10). This state-dependent effect likely 
reflects the fact that the compensatory increases in 5-HT and SP were local and could not counter the 
anesthetic depression of the entire respiratory network. Finally, there is a state-dependent effect of 
dialysis of 50 mM atropine on V�i and f, which led to an overcompensation significantly greater in the 
awake state than during NREM sleep.20 This difference could be due to the state-dependent attenuation 
of excitatory drives for V�i and f at multiple components of the respiratory control network. 
Caveats and limitations. 
The limitations of our laboratory's goat model have been previously published20–23 and are summarized 
here. First, although the target for MT implantation was the preBötC, the exact boundaries of this 
nucleus are not definitively known,16, 33 and, therefore, we cannot conclusively state that MT placement 
was only in the preBötC. Based on histological data, we can conclude that all MTs were placed at 
locations whereby the microdialysis probes were within or directly adjacent to the medullary VRC and in 
the region of the preBötC. It also remains difficult to determine the exact radius of diffusion of the drugs 
dialyzed, leaving the possibility that the concentration of drug that reached the preBötC/VRC may have 
varied between studies and doses of the drugs. In addition, we cannot eliminate the possibility that the 
compensatory responses to drug dialysis occurred at sites other than the preBötC/VRC. 
Another caveat of our dialysis protocol is that, in order to minimize disturbance of the goats during 
studies, we keep the dialysis pump outside of the animal chamber, which necessitates having dead 
space in a length of tubing (~150–180 cm) and a delay of ~15–20 min from the start of drug dialysis to 
when the drug reaches the probe tip. To correct for this delay, the first 15 min of hour 2 of dialysis were 
omitted from statistical analysis. Moreover, during the initial 15–20 min of hour 3, drug delivery to the 
tissue would continue as in hour 2. In addition, thereafter, washout of the drug from the tissue would be 
time dependent. As a result, the sustained hyperpnea in hour 3 (shown in Figs. 2, 6, and 7) likely reflects 
these drug delivery and washout characteristics. Finally, due to the nature of our effluent mCSF 
collection protocol, we were not able to separate neuromodulator content between sleep states, but 
rather have one single neurochemical value for each hour for both day and night studies. 
Conclusions and significance. 
The present findings do not support the hypothesis that absence of decreased breathing during 
unilateral dialysis of excitatory receptor antagonists is due to compensation by the contralateral 
preBötC/VRC. In addition, findings herein show that, during unilateral dialysis of 50 mM atropine, into 
the preBötC/VRC, to block excitatory muscarinic receptor activity, a compensatory increase in other 
neuromodulators is state independent, but the V�i and f response appear to be state dependent. These 
data emphasize the need/value for testing hypotheses, formulated on the basis of data obtained during 
anesthetized/reduced preparations, under physiological wakefulness and sleep states. It seems clear 
that findings herein show that perturbations of neuromodulators at night during the normal sleep 
period have a major disruptive effect on sleep and on breathing during sleep. Finally, we emphasize that 
insights gained herein regarding control of neuromodulators affecting the respiratory control network 
have general application to neuromodulation of all neuronal networks and thus have relevance to 
multiple diseases such as depression, epilepsy, and schizophrenia. 
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